Teriflunomide Structural Formula (Image 01)
Teriflunomide Tablet, Film Coated
Product Images NDC 0378-0628
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 0378-0628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 1) (Image 02)
The text appears to be a table with details about the percentage of disability progression sustained for 12 weeks with different treatments. The table shows the number at risk and the percentage of disability progression for Plcsbo, 7mg Teriflunomide Tablets, and 14mg Terflunomide Tablets. It is not clear what the numbers under "o" and "(@" refer to.*
Figure 2: Kaplan-meier Plot Of Time To Disability Progression Sustained For 12 Weeks (study 2) (Image 03)
This appears to be a medical or pharmaceutical table showing the effectiveness of different tablets in sustaining disability progression for a period of 12 weeks. The tablets are labeled with doses of 7mg and 14mg Terflunomide. The table also includes a placebo group. The number of subjects in each group is shown, as is the percentage of subjects who experienced sustained disability progression during the 12-week period of the study.*
Teriflunomide Tablets 7 mg (Image 04)
Teriflunomide tablets with NDC 0378-0627-93 is a medication that comes in a bottle with 30 film-coated tablets. Pharmacist must dispense medication guide to each patient. It is manufactured by Mylan Pharmaceuticals in Morgantown, WV. It should be stored at room temperature, kept tightly sealed out of reach of children, and protected from light. Recommended dosage is one tablet per day or as prescribed. Further prescription information should be obtained from the accompanying literature.*
Teriflunomide Tablets 14 mg (Image 05)
Teriflunomide tablets are a prescription medication with a National Drug Code of 0378-0628-03. The usual dosage is one tablet taken orally once daily. It is advised to dispense the accompanying medication guide to each patient. It is recommended to store this medication at a controlled room temperature between 20 to 25 degrees Celsius and to keep it in a tight light-resistant container. Each film-coated tablet contains Teriflunomide 14mg.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
